Olink Holding AB (publ)
OLK
Peringkat dalam Saham
#4802
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
Harga Saham
$26.08
Terakhir disinkronkan: 2024-07-09
Kapitalisasi Pasar
$3.10B
Perubahan (1 hari)
0.31%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Olink Holding AB (publ) (OLK)
Kategori
Healthcare
Laba untuk Olink Holding AB (publ) (OLK)
Laba pada Mar 2024 TTM: $-42.44M
Menurut laporan keuangan terbaru dari Olink Holding AB (publ), laba saat ini perusahaan adalah $-42.44M. Pada tahun 2022, perusahaan memperoleh laba sebesar $-15.41M, peningkatan dibandingkan laba tahun 2021 sebesar $-46.55M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Olink Holding AB (publ) dari 2019 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $-42.44M | 6.15% |
| 2023 | $-39.98M | 159.48% |
| 2022 | $-15.41M | -66.90% |
| 2021 | $-46.55M | 541.20% |
| 2020 | $-7.26M | -60.83% |
| 2019 | $-18.53M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $7.61B | -18,029.54% |
US
|
|
| $4.76B | -11,320.98% |
US
|
|
| $-252.70M | 495.45% |
US
|
|
| - | - |
CN
|
|
| $1.66B | -4,006.84% |
US
|
